Fortress Biotech
FBIO
49 hedge funds and large institutions have $33.7M invested in Fortress Biotech in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
499% more call options, than puts
Call options by funds: $838K | Put options by funds: $140K
186% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 7
82% more capital invested
Capital invested by funds: $18.5M → $33.7M (+$15.2M)
36% more funds holding
Funds holding: 36 → 49 (+13)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$1.67M |
| 2 |
RI
RTW Investments
New York
|
+$1.39M |
| 3 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$1.18M |
| 4 |
SIM
Spark Investment Management
New York
|
+$352K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$288K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.57M |
| 2 |
RA
Royce & Associates
New York
|
-$647K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$423K |
| 4 |
Millennium Management
New York
|
-$276K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$227K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$423K | -11,556 | Closed |
|
|
52
Millennium Management
New York
| – | -$276K | -7,537 | Closed |
|
|
BRWA
53
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$665 | -3,113 | Closed |
|
54
Barclays
London,
United Kingdom
| – | -$58K | -1,934 | Closed |
|
|
HCC
55
Hirtle Callaghan & Co
West Conshohocken,
Pennsylvania
| – | -$5K | -138 | Closed |
|
|
LS
56
Lupo Securities
Chicago,
Illinois
| – | -$1.95K | -53 | Closed |
|
FBIO Hedge Fund Activity: Q1 2015 in Review
49 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2015, worth a combined $33.7M — up 82% from $18.5M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FBIO positions and 7 closed out — a net gain of 13 holders — while 9 added to existing stakes and 11 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $1.67M. The largest seller was Invesco, cutting an estimated $1.57M.
- 49 institutional investors held Fortress Biotech (FBIO) as of Q1 2015, up from 36 in Q4 2014.
- Funds reported $33.7M of Fortress Biotech stock for Q1 2015, up 82% quarter-over-quarter.
- 20 funds opened new Fortress Biotech positions in Q1 2015 and 7 closed out, a net change of +13 holders.
- The largest Fortress Biotech buyer in Q1 2015 was Avoro Capital Advisors, an estimated $1.67M added.
- The largest Fortress Biotech seller in Q1 2015 was Invesco, an estimated $1.57M sold.
Based on aggregated 13F filings for Q1 2015.